Visus Therapeutics

Closed

Vision Restoration for Presbyopia, Cataracts, and Geographic Atrophy | Tenpoint Therapeutics™

Headquarters
Warren, New Jersey
Employees
11–50
Business Model
B2B

About

Visus Therapeutics, Inc. is a Warren, New Jersey-based ophthalmic pharmaceutical company developing paradigm-shifting therapeutics for vision conditions with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy. The company's lead product, YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution), targets presbyopia — a gradual loss of near visual acuity affecting millions of aging adults. Visus Therapeutics operates as an affiliate of Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic company. The company works in partnership with eye care professionals including optometrists and ophthalmologists.

Summary

Visus Therapeutics is a Biotech company based in Warren, United States.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Visus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/visus-therapeutics"><img src="https://indexed.vc/api/badge/company/visus-therapeutics" alt="Visus Therapeutics on Indexed.vc" width="260" height="76" /></a>